Peter Knauer, PhD

Peter Knauer has over thirty years of CMC/RA experience in the Biopharma Industry. Peter has served as Vice President of CMC/RA and QC/Analytical for US and International based companies such as Xeris Pharmaceuticals, British Technology Group (BTG), Protherics, Jade Therapeutics and Symic Biomedical. Peter also served as COO of BioUtah. Peter started his career at Genentech, Inc. where he held numerous technical and leadership positions in pharmaceutical development and drug delivery. Peter has directly overseen multiple NDA/BLA/MAA and 510(k)/PMA market authorizations. Peter holds a Master’s Degree in Mechanical Engineering and a Bachelor’s Degree in Materials Science Engineering.